• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TP53 缺失导致输卵管上皮细胞的染色体不稳定。

TP53 loss initiates chromosomal instability in fallopian tube epithelial cells.

机构信息

Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Cancer Research Centre, Wilmslow Road, Manchester M20 4GJ, UK.

Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

出版信息

Dis Model Mech. 2021 Nov 1;14(11). doi: 10.1242/dmm.049001. Epub 2021 Nov 30.

DOI:10.1242/dmm.049001
PMID:34569598
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8649171/
Abstract

High-grade serous ovarian cancer (HGSOC) originates in the fallopian tube epithelium and is characterized by ubiquitous TP53 mutation and extensive chromosomal instability (CIN). However, direct causes of CIN, such as mutations in DNA replication and mitosis genes, are rare in HGSOC. We therefore asked whether oncogenic mutations that are common in HGSOC can indirectly drive CIN in non-transformed human fallopian tube epithelial cells. To model homologous recombination deficient HGSOC, we sequentially mutated TP53 and BRCA1 then overexpressed MYC. Loss of p53 function alone was sufficient to drive the emergence of subclonal karyotype alterations. TP53 mutation also led to global gene expression changes, influencing modules involved in cell cycle commitment, DNA replication, G2/M checkpoint control and mitotic spindle function. Both transcriptional deregulation and karyotype diversity were exacerbated by loss of BRCA1 function, with whole-genome doubling events observed in independent p53/BRCA1-deficient lineages. Thus, our observations indicate that loss of the key tumour suppressor TP53 is sufficient to deregulate multiple cell cycle control networks and thereby initiate CIN in pre-malignant fallopian tube epithelial cells. This article has an associated First Person interview with the first author of the paper.

摘要

高级别浆液性卵巢癌(HGSOC)起源于输卵管上皮,其特征为广泛存在 TP53 突变和广泛的染色体不稳定性(CIN)。然而,CIN 的直接原因,如 DNA 复制和有丝分裂基因的突变,在 HGSOC 中很少见。因此,我们想知道在非转化的人输卵管上皮细胞中,HGSOC 中常见的致癌突变是否可以间接驱动 CIN。为了模拟同源重组缺陷的 HGSOC,我们依次突变 TP53 和 BRCA1,然后过表达 MYC。单独丧失 p53 功能足以驱动亚克隆核型改变的出现。TP53 突变还导致了全局基因表达变化,影响了涉及细胞周期启动、DNA 复制、G2/M 检查点控制和有丝分裂纺锤体功能的模块。BRCA1 功能丧失加剧了转录失调和核型多样性,在独立的 p53/BRCA1 缺陷谱系中观察到全基因组倍增事件。因此,我们的观察表明,关键肿瘤抑制因子 TP53 的丧失足以使多个细胞周期控制网络失调,并由此在癌前输卵管上皮细胞中引发 CIN。本文有一篇与该论文第一作者的相关第一人称采访。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3398/8649171/9eb10313e265/dmm-14-049001-g7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3398/8649171/6b77321897e9/dmm-14-049001-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3398/8649171/0b989ca3447a/dmm-14-049001-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3398/8649171/d9e78515de49/dmm-14-049001-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3398/8649171/c0cbc63e5e9f/dmm-14-049001-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3398/8649171/a7d30e4dfa54/dmm-14-049001-g5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3398/8649171/d03be02e19d3/dmm-14-049001-g6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3398/8649171/9eb10313e265/dmm-14-049001-g7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3398/8649171/6b77321897e9/dmm-14-049001-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3398/8649171/0b989ca3447a/dmm-14-049001-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3398/8649171/d9e78515de49/dmm-14-049001-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3398/8649171/c0cbc63e5e9f/dmm-14-049001-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3398/8649171/a7d30e4dfa54/dmm-14-049001-g5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3398/8649171/d03be02e19d3/dmm-14-049001-g6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3398/8649171/9eb10313e265/dmm-14-049001-g7.jpg

相似文献

1
TP53 loss initiates chromosomal instability in fallopian tube epithelial cells.TP53 缺失导致输卵管上皮细胞的染色体不稳定。
Dis Model Mech. 2021 Nov 1;14(11). doi: 10.1242/dmm.049001. Epub 2021 Nov 30.
2
[Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].[PAX8、PAX2、p53和RAS在卵巢及输卵管中的表达及其对卵巢高级别浆液性癌起源的意义]
Zhonghua Fu Chan Ke Za Zhi. 2017 Oct 25;52(10):687-696. doi: 10.3760/cma.j.issn.0529-567X.2017.10.008.
3
Quantitative analysis of γ-H2AX and p53 nuclear expression levels in ovarian and fallopian tube epithelium from risk-reducing salpingo-oophorectomies in BRCA1 and BRCA2 mutation carriers.对BRCA1和BRCA2突变携带者进行降低风险的输卵管卵巢切除术所获得的卵巢和输卵管上皮中γ-H2AX和p53核表达水平的定量分析。
Int J Gynecol Pathol. 2014 May;33(3):309-16. doi: 10.1097/PGP.0b013e31829c673b.
4
Immunohistochemical and molecular pattern of p53 in epithelial ovarian cancers negative for germline BRCA1/2 variants.种系BRCA1/2变异阴性的上皮性卵巢癌中p53的免疫组织化学和分子模式
Pathol Res Pract. 2024 Mar;255:155183. doi: 10.1016/j.prp.2024.155183. Epub 2024 Feb 1.
5
Molecular requirements for transformation of fallopian tube epithelial cells into serous carcinoma.将输卵管上皮细胞转化为浆液性癌的分子要求。
Neoplasia. 2011 Oct;13(10):899-911. doi: 10.1593/neo.11138.
6
Both fallopian tube and ovarian surface epithelium are cells-of-origin for high-grade serous ovarian carcinoma.输卵管和卵巢表面上皮都是高级别浆液性卵巢癌的起源细胞。
Nat Commun. 2019 Nov 26;10(1):5367. doi: 10.1038/s41467-019-13116-2.
7
Human Fallopian Tube-Derived Organoids with TP53 and RAD51D Mutations Recapitulate an Early Stage High-Grade Serous Ovarian Cancer Phenotype In Vitro.携带有 TP53 和 RAD51D 突变的人输卵管衍生类器官在体外重现早期高级别浆液性卵巢癌表型。
Int J Mol Sci. 2024 Jan 10;25(2):886. doi: 10.3390/ijms25020886.
8
Cytomorphologic and molecular analyses of fallopian tube fimbrial brushings for diagnosis of serous tubal intraepithelial carcinoma.输卵管壶腹部刷取物的细胞形态学和分子分析用于诊断浆液性输卵管上皮内癌。
Cancer Cytopathol. 2019 Mar;127(3):192-201. doi: 10.1002/cncy.22110. Epub 2019 Mar 12.
9
Two different, mutually exclusively distributed, mutations in ovarian and peritoneal tumor tissues of a serous ovarian cancer patient: indicative for tumor origin?一名浆液性卵巢癌患者的卵巢和腹膜肿瘤组织中存在两种不同的、相互排斥分布的突变:这是否表明肿瘤的起源?
Cold Spring Harb Mol Case Stud. 2017 Jul 5;3(4). doi: 10.1101/mcs.a001461. Print 2017 Jul.
10
Whence High-Grade Serous Ovarian Cancer.高级别浆液性卵巢癌的起源
Am Soc Clin Oncol Educ Book. 2017;37:443-448. doi: 10.1200/EDBK_174718.

引用本文的文献

1
Metabolic Reprogramming Shapes the Progression and Therapeutic Landscape of Ovarian Cancer.代谢重编程塑造卵巢癌的进展和治疗格局。
Cancer Manag Res. 2025 Aug 19;17:1707-1722. doi: 10.2147/CMAR.S538281. eCollection 2025.
2
Role of DNA methylation and non‑coding RNAs expression in pathogenesis, detection, prognosis, and therapy‑resistant ovarian carcinoma (Review).DNA甲基化和非编码RNA表达在卵巢癌发病机制、检测、预后及治疗抵抗中的作用(综述)
Mol Med Rep. 2025 Jun;31(6). doi: 10.3892/mmr.2025.13509. Epub 2025 Apr 4.
3
Aged and BRCA-Mutated Stromal Cells Drive Epithelial Cell Transformation.

本文引用的文献

1
Clonal fitness inferred from time-series modelling of single-cell cancer genomes.从单细胞癌症基因组的时间序列建模推断克隆适应性。
Nature. 2021 Jul;595(7868):585-590. doi: 10.1038/s41586-021-03648-3. Epub 2021 Jun 23.
2
Overexpression of Cyclin E1 or Cdc25A leads to replication stress, mitotic aberrancies, and increased sensitivity to replication checkpoint inhibitors.细胞周期蛋白E1或细胞周期蛋白依赖性激酶25A(Cdc25A)的过表达会导致复制应激、有丝分裂异常,并增加对复制检查点抑制剂的敏感性。
Oncogenesis. 2020 Oct 7;9(10):88. doi: 10.1038/s41389-020-00270-2.
3
Specific Mechanisms of Chromosomal Instability Indicate Therapeutic Sensitivities in High-Grade Serous Ovarian Carcinoma.
衰老和BRCA突变的基质细胞驱动上皮细胞转化。
Cancer Discov. 2025 Jun 3;15(6):1203-1224. doi: 10.1158/2159-8290.CD-24-0805.
4
Coordinated protein modules define DNA damage responses to carboplatin at single cell resolution in human ovarian carcinoma models.在人卵巢癌模型中,协调的蛋白质模块以单细胞分辨率定义了对卡铂的DNA损伤反应。
bioRxiv. 2024 Nov 26:2024.11.21.624591. doi: 10.1101/2024.11.21.624591.
5
Mutational spectrum of breast cancer by shallow whole-genome sequencing of cfDNA and tumor gene panel analysis.cfDNA 浅层全基因组测序和肿瘤基因panel 分析乳腺癌的突变图谱
PLoS One. 2024 Sep 12;19(9):e0308176. doi: 10.1371/journal.pone.0308176. eCollection 2024.
6
Intrinsic PARG inhibitor sensitivity is mimicked by haploinsufficiency and rescued by nucleoside supplementation.单倍剂量不足可模拟PARG内在抑制剂敏感性,核苷补充可挽救该敏感性。
NAR Cancer. 2024 Jul 16;6(3):zcae030. doi: 10.1093/narcan/zcae030. eCollection 2024 Sep.
7
Aneuploidy and complex genomic rearrangements in cancer evolution.癌症进化中的非整倍体和复杂基因组重排。
Nat Cancer. 2024 Feb;5(2):228-239. doi: 10.1038/s43018-023-00711-y. Epub 2024 Jan 29.
8
Rescue of p53 functions by in vitro-transcribed mRNA impedes the growth of high-grade serous ovarian cancer.体外转录 mRNA 挽救 p53 功能可阻碍高级别浆液性卵巢癌的生长。
Cancer Commun (Lond). 2024 Jan;44(1):101-126. doi: 10.1002/cac2.12511. Epub 2023 Dec 22.
9
Molecular cartography uncovers evolutionary and microenvironmental dynamics in sporadic colorectal tumors.分子图谱揭示散发性结直肠肿瘤中的进化和微环境动态。
Cell. 2023 Dec 7;186(25):5620-5637.e16. doi: 10.1016/j.cell.2023.11.006.
10
Biallelic MAD2L1BP (p31comet) mutation is associated with mosaic aneuploidy and juvenile granulosa cell tumors.双等位基因 MAD2L1BP(p31comet)突变与镶嵌性非整倍体和幼年型颗粒细胞瘤相关。
JCI Insight. 2023 Nov 22;8(22):e170079. doi: 10.1172/jci.insight.170079.
特定的染色体不稳定性机制表明高级别浆液性卵巢癌的治疗敏感性。
Cancer Res. 2020 Nov 15;80(22):4946-4959. doi: 10.1158/0008-5472.CAN-19-0852. Epub 2020 Sep 30.
4
p53 deficiency triggers dysregulation of diverse cellular processes in physiological oxygen.p53 缺陷在生理氧中触发多种细胞过程的失调。
J Cell Biol. 2020 Nov 2;219(11). doi: 10.1083/jcb.201908212.
5
Dissecting transcriptional amplification by MYC.解析 MYC 的转录扩增。
Elife. 2020 Jul 27;9:e52483. doi: 10.7554/eLife.52483.
6
Proteogenomic Characterization of Ovarian HGSC Implicates Mitotic Kinases, Replication Stress in Observed Chromosomal Instability.卵巢高恶性浆液性癌的蛋白质基因组学特征提示有丝分裂激酶、复制应激与观察到的染色体不稳定性有关。
Cell Rep Med. 2020 Apr 21;1(1). doi: 10.1016/j.xcrm.2020.100004. Epub 2020 Apr 10.
7
Unraveling tumor-immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapy.解析晚期卵巢癌肿瘤免疫异质性揭示化疗的免疫原性效应。
Nat Genet. 2020 Jun;52(6):582-593. doi: 10.1038/s41588-020-0630-5. Epub 2020 Jun 1.
8
MYC Dysregulates Mitosis, Revealing Cancer Vulnerabilities.MYC 扰乱有丝分裂,揭示癌症弱点。
Cell Rep. 2020 Mar 10;30(10):3368-3382.e7. doi: 10.1016/j.celrep.2020.02.041.
9
A living biobank of ovarian cancer ex vivo models reveals profound mitotic heterogeneity.卵巢癌体外模型的活体生物银行揭示了深刻的有丝分裂异质性。
Nat Commun. 2020 Feb 13;11(1):822. doi: 10.1038/s41467-020-14551-2.
10
Chromosome arm aneuploidies shape tumour evolution and drug response.染色体臂非整倍性塑造肿瘤进化和药物反应。
Nat Commun. 2020 Jan 23;11(1):449. doi: 10.1038/s41467-020-14286-0.